CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 03/31/2014

Position Statistics

Total Positions 58
New Positions 20
Increased Positions 34
Decreased Positions 18
Positions with Activity 52
Sold Out Positions 11
Total Mkt Value (in $ millions) 460

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 5.29%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 82.8%
Services
Technology
Transportation
Utilities

58 Positions as of 03/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
OMEROS CORP COM 6,990 6,990 New 500,000
CHIMERIX INC COM 6,738 3,526 109.79 300,000
PROTHENA CORP PLC SHS 6,377 6,377 New 350,000
ACADIA PHARMACEUTICALS COM 6,186 -10,310 (62.5) 300,000
GALECTIN THERAPEUTICS INC COM NEW 5,331 5,331 New 348,000
EAGLE PHARMACEUTICALS INC COM 5,064 5,064 New 400,000
NANOSTRING TECHNOLOGIES INC COM 4,944 4,944 New 400,000
PORTOLA PHARMACEUTICALS INC COM 4,888 3,055 166.67 200,000
CLOVIS ONCOLOGY INC COM 4,522 26 .59 120,000
NOVAVAX INC COM 4,400 New 1,000,000
PACIRA PHARMACEUTICALS INC COM 4,277 New 50,000
ROCKWELL MED INC COM 4,084 4,084 New 400,000
GLYCOMIMETICS INC COM 4,079 4,079 New 469,400
GERON CORP COM 3,630 -4,591 (55.85) 1,500,000
SORRENTO THERAPEUTICS INC COM NEW 3,619 3,619 New 700,000
BIOGEN IDEC INC COM 3,355 3,355 New 10,000
AGENUS INC COM NEW 3,240 3,240 New 1,000,000
RECRO PHARMA INC COM 2,908 2,908 New 500,000
GENVEC INC COM NEW 2,871 2,871 New 1,329,300
ALNYLAM PHARMACEUTICALS INC COM 2,742 -10,966 (80) 50,000